Bioventix (BVXP)

Currency in GBP
1,550.0
-25.0(-1.59%)
Closed·
High dividend Yield
BVXP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,550.01,600.0
52 wk Range
1,300.02,860.0
Key Statistics
Bid/Ask
1,500.00 / 1,700.00
Prev. Close
1,575
Open
1,575
Day's Range
1,550-1,600
52 wk Range
1,300-2,860
Volume
2.79K
Average Volume (3m)
8.59K
1-Year Change
-43.1193%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BVXP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Bioventix News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Earnings

Latest Release
30/03/2026
EPS / Forecast
0.68 / --
Revenue / Forecast
6.16M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.41%
Dividend Yield
9.52%
Industry Median 1.04%
Annualised payout
150.00
Paid unevenly
5-Years Growth
+9.57%
Growth Streak

Compare BVXP to Peers and Sector

Metrics to compare
BVXP
Peers
Sector
Relationship
P/E Ratio
11.1x−3.4x−0.4x
PEG Ratio
−2.16−0.010.00
Price/Book
7.5x2.7x2.6x
Price / LTM Sales
6.6x5.3x3.1x
Upside (Analyst Target)
147.6%114.1%51.8%
Fair Value Upside
Unlock−1.3%7.5%Unlock

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. It offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit to monitor human exposure to industrial pollutants; and Pyrene (HOP-G) lateral flow kits for monitoring of at-risk individuals without laboratory equipment. The company also provides contract SMAs services; and industrial and environmental biomonitoring platform, which reduces the time between sampling and results. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
2.03M38.88%32.00M
Other Institutional Investors
2.33M44.57%36.68M
Public Companies & Retail Investors
864.60K16.55%13.62M
Total
5.22M100.00%82.29M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Gresham House Asset Management Limited12.16%635,28210,006
Liontrust Asset Management PLC10.62%554,9388,740

FAQ

What Is the Bioventix (London: BVXP) Share Price Today?

The Bioventix stock price today is 1,550.0 GBP.

What Stock Exchange Does Bioventix (BVXP) Trade On?

Bioventix is listed and trades on the London Stock Exchange.

What Is the Ticker (Stock Symbol) for Bioventix?

The stock symbol (also called a 'ticker') for Bioventix is "BVXP."

Does Bioventix Pay Dividends? What’s The Current BVXP Dividend Yield?

Yes, BVXP Pays Dividends to its Shareholders. The current Bioventix dividend yield is 9.68%.

What Is the Current Bioventix Market Capitalisation?

As of today, Bioventix (London: BVXP) market cap is 81.66M GBP.

What Is Bioventix's (BVXP) Earnings Per Share (TTM)?

The Bioventix EPS is currently 1.4 (Trailing Twelve Months).

When Is the Next Bioventix Earnings Date?

Bioventix's next earnings report will be released on 30/03/2026.

Is BVXP a Buy or Sell From a Technical Analyst Perspective?

Based on today's Bioventix moving averages and other technical indicators, the daily buy/sell signal for BVXP stock is Strong Sell.

How Many Times Has Bioventix Stock Split?

Bioventix has split 0 times. (See the BVXP stock split history page for full effective split date and price information.)

How Many Employees Does Bioventix Have?

Bioventix has 12 employees, based on their latest Companies House report.

What is the current trading status of Bioventix (London: BVXP)?

As of 16/07/2026, Bioventix (BVXP) is trading at a share price of 1,550.0 GBP, with a previous close of 1,575.0 GBP. The stock has fluctuated within a day range of 1,550.0 GBP to 1,600.0 GBP, while its 52-week range spans from 1,300.0 GBP to 2,860.0 GBP.

What Is Bioventix (BVXP) Price Target According to Analysts?

The average 12-month price target for Bioventix is 3,900.0 GBP, with a high estimate of 3900 GBP and a low estimate of 3900 GBP. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +151.61% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.